Literature DB >> 29880311

In-utero ART exposure and the need for pharmacovigilance.

Lynne M Mofenson1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29880311     DOI： 10.1016/S2214-109X(18)30272-9

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  5 in total

1.  Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana.

Authors:  Rebecca Zash; Lewis Holmes; Modiegi Diseko; Denise L Jacobson; Sean Brummel; Gloria Mayondi; Arielle Isaacson; Sonya Davey; Judith Mabuta; Mompati Mmalane; Tendani Gaolathe; M Essex; Shahin Lockman; Joseph Makhema; Roger L Shapiro
Journal:  N Engl J Med       Date:  2019-07-22       Impact factor: 91.245

2.  Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model.

Authors:  Laurent Mandelbrot; Pierre-François Ceccaldi; Dominique Duro; Minh Lê; Lucile Pencolé; Gilles Peytavin
Journal:  PLoS One       Date:  2019-08-13       Impact factor: 3.240

3.  Maternal Factors Associated With Infant Neurodevelopment in HIV-Exposed Uninfected Infants.

Authors:  Maria L Alcaide; Violeta J Rodriguez; John M Abbamonte; Shandir Ramlagan; Sibusiso Sifunda; Stephen M Weiss; Karl Peltzer; Deborah L Jones
Journal:  Open Forum Infect Dis       Date:  2019-10-09       Impact factor: 3.835

4.  Prevalence of neural tube defects, maternal HIV status, and antiretroviral therapy from a hospital-based birth defect surveillance in Kampala, Uganda.

Authors:  Linda Barlow-Mosha; Robert Serunjogi; Dennis Kalibbala; Daniel Mumpe-Mwanja; Dhelia Williamson; Diana Valencia; Sarah C Tinker; Joyce Namale Matovu; Cynthia A Moore; Michelle R Adler; Lisa Nelson; Jolly Nankunda; Evelyn Nabunya; Doreen Birabwa-Male; Philippa Musoke
Journal:  Birth Defects Res       Date:  2021-11-11       Impact factor: 2.661

5.  Neurodevelopment of HIV-exposed uninfected children in Cape Town, South Africa.

Authors:  Hlengiwe P Madlala; Landon Myer; Thokozile R Malaba; Marie-Louise Newell
Journal:  PLoS One       Date:  2020-11-18       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.